Moving beyond broadly immunosuppressive agents, newer therapies for AD offer more targeted immunomodulation in the forms of phosphodiesterase 4 inhibitors, Janus kinase inhibitors, and anticytokine monoclonal antibodies.
Cutaneous inflammatory conditions such as psoriasis, atopic dermatitis, alopecia areata, vitiligo, and connective tissue diseases often remain a challenge to treat.
Patch testing is essential for identification of culprit allergens responsible for allergic contact dermatitis. This manuscript reviews how to perform patch testing and how to read and interpret the results.
Semin Cutan Med Surg 32:158-168 © 2013 Frontline Medical Communications